Topline
Trials of cutting-edge cancer vaccines could kick off in the U.K. as soon as September, German Covid vaccine maker BioNTech announced on Friday, part of a new government partnership to fast track development of the same mRNA technology behind the most successful coronavirus vaccines as companies race to build upon pandemic successes and target other diseases.
An employee holds